Connect Sign In
Connect with ARUP experts to learn about our comprehensive neurology testing suites and how intentional lab testing can support clinically meaningful insights across a range of neurologic conditions.
Kanako Yumioka’s journey from Housekeeping to Specimen Processing shows how mentorship, support, and a “warmful” culture help employees grow and find their path at ARUP Laboratories.
Tracy George, MD, is a champion for patients with rare and undiagnosed conditions and will speak about ARUP’s innovative efforts that support the rare disease community.
ARUP’s Innovation Central Laboratory will serve as an ecosystem for validating technologies and accelerating next generation diagnostics from concept to commercialization.
ARUP scientists authored more than 130 peer-reviewed publications and presented at over 100 conferences in 2025, highlighting a year of research, innovation, and progress in diagnostic medicine.
RIDGEWATER, N.J.—Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders
ARUP experts will showcase their latest research at the ASH Annual Meeting and Exposition, including updates on key clinical trials and the development of automated disease scoring.
ARUP has used novel statistical modeling approaches to establish age-specific reference ranges for pediatric patients, facilitating more accurate diagnoses of G6PD deficiency.
An article describing ARUP’s validation of an artificial intelligence (AI) solution to detect gastrointestinal parasites in wet mounts has been published in the Journal of Clinical Microbiology.
ARUP’s central pathology review service has provided key support for the Cogent SUMMIT trial through robust laboratory testing, mastocytosis pathology expertise, and rigorous quality standards.
ARUP has launched a highly sensitive and fully automated molecular assay to detect hepatitis delta virus (HDV) that will facilitate better detection of the virus.
At upcoming conferences, ARUP experts will highlight a new blood-based biomarker assay for Alzheimer’s disease and share a presentation on building a successful laboratory outreach program.
